You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Therapy Areas: Devices
New Study Finds That Masimo PVi Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosurgery
Login
Username:

Password:


Related Headlines

Abbott receives CE Mark for Volt Pulsed Field Ablation System to treat atrial fibrillation

Vast Therapeutics' ALX1 drug candidate granted QIDP designation by US FDA

Qlife secures UK approval to initiate clinical trial for Egoo Phe System

Dassault Systèmes invests in Click Therapeutics to expand digital therapeutics beyond clinical trials

Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services

Femasys receives CE mark approval for FemBloc delivery system in Europe

Avance Biosciences registers with CLIA program

Abbott announces quarterly common dividend

Aiforia secures IVDR certification for expanded AI-powered cancer diagnostics in Europe

Limaca Medical launches Precision-GI endoscopic automated motorised EUS biopsy device in US

Owens & Minor launches ByramConnect digital health platform for diabetes management

Acrivon Therapeutics receives FDA Breakthrough Device designation for ACR-368 OncoSignature assay

BrainCool secures market approval for BrainCool System in Malaysia

Bioretec Ltd secures CE mark approval for RemeOs Trauma Screw portfolio

Biohit launches FAEX Sample System for stool sample collection

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2025